学术探索
学术期刊
新闻热点
数据分析
智能评审

BEZAFIBRATE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERLIPEMIA

被引：128
作者：
MONK, JP
TODD, PA
机构：
来源：
DRUGS | 1987年 / 33卷 / 06期
关键词：
D O I：
10.2165/00003495-198733060-00002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：539 / 576
页数：38
相关论文
共 132 条
  • [1] DISPOSITION PHARMACOKINETICS OF BEZAFIBRATE IN MAN
    ABSHAGEN, U
    BABLOK, W
    KOCH, K
    LANG, PD
    SCHMIDT, HAE
    SENN, M
    STORK, H
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (01) : 31 - 38
  • [2] STEADY-STATE KINETICS OF BEZAFIBRATE AND CLOFIBRATE IN HEALTHY FEMALE VOLUNTEERS
    ABSHAGEN, U
    SPORLRADUN, S
    MARINOW, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (04) : 305 - 308
  • [3] PHARMACOKINETICS OF BEZAFIBRATE AFTER SINGLE AND MULTIPLE DOSES IN THE PRESENCE OF RENAL-FAILURE
    ABSHAGEN, U
    KOSTERS, W
    KAUFMANN, B
    LANG, PD
    [J]. KLINISCHE WOCHENSCHRIFT, 1980, 58 (17): : 889 - 896
  • [4] ADAM O, 1979, MUNCHEN MED WOCHEN, V121, P319
  • [5] THE FIBRINOLYTIC SYSTEM AND COAGULATION DURING BEZAFIBRATE TREATMENT OF HYPERTRIGLYCERIDEMIA
    ALMER, LO
    KJELLSTROM, T
    [J]. ATHEROSCLEROSIS, 1986, 61 (01) : 81 - 85
  • [6] CLINICAL PHARMACOKINETICS OF BEZAFIBRATE IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    ANDERSON, P
    NORBECK, HE
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (03) : 209 - 214
  • [7] ARNTZ HR, 1985, MUNCHEN MED WOCHEN, V127, P206
  • [8] ARNTZ HR, 1981, CLIN TRIALS J, V18, P280
  • [9] ARNTZ HR, 1987, IN PRESS MUNCHENER M
  • [10] DIET, LIPOPROTEINS, AND THE PROGRESSION OF CORONARY ATHEROSCLEROSIS - THE LEIDEN INTERVENTION TRIAL
    ARNTZENIUS, AC
    KROMHOUT, D
    BARTH, JD
    REIBER, JHC
    BRUSCHKE, AVG
    BUIS, B
    VANGENT, CM
    KEMPENVOOGD, N
    STRIKWERDA, S
    VANDERVELDE, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) : 805 - 811
12345678910